Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,477.16
(
-1.74%
)
US TECH 100
22,818.00
(
-0.58%
)
Dow Jones
45,960.11
(
0.00%
)
Brent Oil
104.51
(
3.81%
)
Bitcoin
66,754.00
(
-2.95%
)
News Focus
News Focus
Post# of 257295
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Bickema

Send PM Follow Ignore
Followers 19
Posts 1632
Boards Moderated 0
Alias Born 11/10/2010

Bickema

Re: caravon post# 179574

Friday, 06/20/2014 12:29:42 PM

Friday, June 20, 2014 12:29:42 PM

Post# of 257295
I figured there wasn't much to take away from the potential deal. After all, as you said, 2-3 Billion is nothing for ABBV.

What I really want to know is what ENTA's plans for their increasingly growing cash position.

I guess it would be smart to conserve capital until first full quarter of sales are in for their lead Hep C drug.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today